MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia

References

• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Vasilatou D, Papageorgiou S, Pappa V, . The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol 2010;84:1–16.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006;66:7390–7394.
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006;11:441–450.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. pp 179–267.
   Google Scholar
• Zhang J, Jima DD, Jacobs C, . Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009;113:4586–4594.
   PubMed Web of Science ®Google Scholar
• Malumbres R, Sarosiek KA, Cubedo E, . Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009;113:3754–3764.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, . A microRNA polycistron as a potential human oncogene. Nature 2005;435:828–833.
   PubMed Web of Science ®Google Scholar
• Mraz M, Pospisilova S, Malinova K, . MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009;50:506–509.
   PubMed Web of Science ®Google Scholar
• Fulci V, Chiaretti S, Goldoni M, . Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007;109:4944–4951.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B, Meuleman N, Haibe-Kains B, . microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009;113:5237–5245.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Brüggemann M, . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Qiu HX, Xu W, Cao XS, . Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 2008;49:1887–1892.
   PubMed Web of Science ®Google Scholar
• Xu W, Li JY, Wu YJ, . Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008;32:1071–1077.
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Zhao S, Mason DY, . The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 2007;109:1636–1642.
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Farinha P, Hsi ED, . LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 2008;26:447–454.
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B, Loos U, Ludwig WD. TTG-2: a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 1991;6: 1887–1893.
   PubMed Web of Science ®Google Scholar
• Wadman IA, Osada H, Grütz GG, . The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 1997;16:3145–3157.
   PubMed Web of Science ®Google Scholar
• Liu TY, Chen SU, Kuo SH, . E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response. Mod Pathol 2010;23:1507–1517.
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, . Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99: 15524–15529.
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A, . A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
   PubMed Web of Science ®Google Scholar
• Haferlach C, Dicker F, Schnittger S, . Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007;21:2442–2451.
   PubMed Web of Science ®Google Scholar
• Reddy KS. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol 2006;132:705–722.
   PubMed Web of Science ®Google Scholar
• Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005;158:88–91.
   PubMed Web of Science ®Google Scholar
• Mittal AK, Hegde GV, Aoun P, . Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Int J Mol Med 2007; 20:461–469.
   PubMed Web of Science ®Google Scholar
• Athanasiadou A, Stamatopoulos K, Tsompanakou A, . Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Cancer Genet Cytogenet 2006;168:109–119.
   PubMed Web of Science ®Google Scholar
• Visone R, Rassenti LZ, Veronese A, . Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009;114: 3872–3879.
   PubMed Web of Science ®Google Scholar